The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

about

Fucoidans in Nanomedicine

P2860

Q26739976-03C2C0DA-A257-4C9B-8EA4-BBB38BFDF3A1

P2860

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

Item

http://www.wikidata.org/entity/Q51639424

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

@en

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

@nl

type

Item

label

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

@en

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

@nl

prefLabel

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

@en

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

@nl

P1476

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

@en

P2093

Cédric Chauvierre

http://www.w3.org/2001/XMLSchema#string

P2860

Polysaccharide nanosystems for future progress in cardiovascular pathologies

Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging.

Nanomedicine as a strategy to fight thrombotic diseases.

Perspectives and opportunities for nanomedicine in the management of atherosclerosis.

Carotid plaque vulnerability: a positive feedback between hemodynamic and biochemical mechanisms.

From bacteria to mollusks: the principles underlying the biomineralization of iron oxide materials.

Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.

A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice.

Ethical and social issues in nanobiotechnologies: Nano2Life provides a European ethical 'think tank' for research in biology at the nanoscale

Flow cytometry for intracellular SPION quantification: specificity and sensitivity in comparison with spectroscopic methods.

P304

3391-3400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.15.170

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Didier Letourneur

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284185456

http://www.w3.org/2001/XMLSchema#string

P698

26582278

http://www.w3.org/2001/XMLSchema#string

P921

nanotechnology

cardiovascular disease

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

about

P2860

P2860

The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921